Founded in 2017, Hebei Deqi Bio-Technology has grown over 8 years into a group with three subsidiary companies, with main products including APIs such as amoxicillin trihydrate, amprolium, ivermectin, levamisole, benzylpenicillin procaine, penicillin V potassium, streptomycin sulfate, tylosin tartrate, lincomycin HCl, trimethoprim, albendazole and florfenicol, along with vitamin C series products.

No comments available.
Leave your rating & comment